Lly stock price target

Turning to Wall Street, analysts have a Strong Buy consensus rating on LLY stock based on 16 Buys, one Hold, and zero Sells assigned in the past three months, as indicated by the graphic above. Furthermore, the average price target of $599.56 per share implies 7.10% upside potential..

According to the issued ratings of 11 analysts in the last year, the consensus rating for BlackRock stock is Moderate Buy based on the current 2 hold ratings and 9 buy ratings for BLK. The average twelve-month price prediction for BlackRock is $762.08 with a high price target of $897.00 and a low price target of $542.00.BofA Securities Raises Price Target on Eli Lilly to $700 From $600 on Obesity Drugs Lineup, Maintains Buy Rating Oct. 06: MT ANALYST RECOMMENDATIONS : Adobe, Apple, Dell, Eli Lilly, NatWest... Sep. 19: Argus Research Raises Price Target on Eli Lilly to $620 From $470, Maintains Buy RatingEli Lilly Company Info. Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology ...

Did you know?

Eli Lilly and Company. Analyst Report: Lilly (Eli) & Co Eli Lilly, based in Indianapolis, develops and manufactures therapies to treat pain, diabetes, cancer, and neurodegenerative diseases. The ...Price target. 631.67R USD +47.63 +8.15%. The 25 analysts offering 1 year price forecasts for Eli Lilly and Company have a max estimate of 722.00 and a min estimate of 430.00. ELI LILLY AND COMPANY (LLY) Dividend Data. Stock Data. Avg Price Recovery. 6.2 Days. Best dividend capture stocks in Dec. Payout Ratio (FWD) 36.77%. Years of Dividend Increase.

Jun 23, 2022 · The highest LLY stock price target was $369 and the lowest $264. Of the 14 analysts covering Eli Lilly tracked by TipRanks, 10 recommended a ‘buy’ and 4 had a ‘sell’ call. The analysts offered an average 12-month price target for LLY’s stock price of $325.58 a share, representing 9.42% change from the 21 June closing price of $297.34. Based on analysts offering 12 month price targets for LLY in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Sep 6, 2023 · The adjustment involved an increase in the price target from $435.00 to a more bullish target of $484.00. This alteration signifies a 23% upside potential for mong stock compared to its current ... With a trading volume of 1,031,657, the price of LLY is up by 0.12%, reaching $592.22. ... 5 market experts have recently issued ratings for this stock, with a consensus target price of $629.4.Jul 28, 2023 · LLY 5Y P/E Valuations. As market analysts increasingly turn optimistic on the stock, LLY's valuations have also unfortunately turned bloated and "fat" at NTM P/E 49.20x, compared to its 1Y mean of ...

Price Targets are an analyst's best guess at where the stock will trade in 12 months. ... The latest price target for . Eli Lilly (NYSE: LLY) was reported by Cantor Fitzgerald on …Analyst Price Forecast Suggests 0.56% Downside As of November 1, 2023, the average one-year price target for Lilly is 615.64. The forecasts range from a low of 343.40 to a high of $745.50. ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Lly stock price target. Possible cause: Not clear lly stock price target.

Nov 29, 2023 · Complete Eli Lilly & Co. stock information by Barron's. View real-time LLY stock price and news, along with industry-best analysis. ... Average price target from 30 ratings: $628.47. Average score ... The path to $1 trillion. Today, Eli Lilly's market cap is a little north of $410 billion, which puts it among the top handful of big pharma companies. That means it'd need to grow by nearly 166% ...Lilly's Donanemab Significantly Slowed Cognitive and ... - Investors

Price Target $559.08. Earnings. Stock Analysis; Analyst Forecasts; Chart; Competitors; Dividend; Earnings; ... Get the Latest News and Ratings for LLY and Related Stocks. ... LLY) has a trailing price-to-earnings ratio of 105.80 and a forward price-to-earnings ratio of 88.22. The price/earnings-to-growth ratio is 3.55.Morgan Stanley analyst Terence Flynn maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price target of $507.00. The company’s shares closed last Friday at $434.43.

pccox 14 analysts have issued 1-year target prices for Citigroup's stock. Their C share price targets range from $43.00 to $85.00. On average, they anticipate the company's share price to reach $51.66 in the next twelve months. This suggests a possible upside of 9.4% from the stock's current price.Sep 11, 2023 · This gets me to a five-year target price of $1,020. $22.67 X 45=$1,020 When this target price is compared with its current price of $586.46, this represents an upside potential of 74% over the ... boyd gaming corptradovate monthly fees Lilly Reports First-Quarter 2023 Financial Results, Highlights ... government shutdown odds Eli Lilly & Co (LLY) BMO Capital analyst Evan Seigerman maintained a Buy rating on Eli Lilly & Co on September 15 and set a price target of $633.00. The company’s shares closed last Friday at ...A new take on Eli Lilly (LLY-2.15%) stock by a prominent bank sent the pharmaceutical company's share price 3% higher on Monday. ... Bansal also cranked his price target on the stock higher, to ... how much does ninjatrader costtrading view pricingvanguard sandp 500 etf dividend The average LLY stock price target of $645.44 implies 7.99% upside potential from current levels. Bottom Line ...LLY<br /> seems to be an invalid ticker. Please provide a valid Ticker. Eli Lilly and Company (LLY) Shows Strong Performance in Stock Market. On December 4, 2023, Eli Lilly and Company (LLY) exhibited a strong performance in the stock market, trading near the top of its 52-week range and above its 200-day simple moving average. best health insurance companies in ga The above table shows the analyst LLY forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$584.04 pfd stock1964 silver kennedy half dollar valuequebec old town Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the …According to the issued ratings of 16 analysts in the last year, the consensus rating for Ally Financial stock is Hold based on the current 3 sell ratings, 8 hold ratings and 5 buy ratings for ALLY. The average twelve-month price prediction for Ally Financial is $29.80 with a high price target of $40.00 and a low price target of $20.00.